[go: up one dir, main page]

WO2008010008A3 - Cardiovascular combinations using rennin-angiotensin inhibitors - Google Patents

Cardiovascular combinations using rennin-angiotensin inhibitors Download PDF

Info

Publication number
WO2008010008A3
WO2008010008A3 PCT/IB2006/002252 IB2006002252W WO2008010008A3 WO 2008010008 A3 WO2008010008 A3 WO 2008010008A3 IB 2006002252 W IB2006002252 W IB 2006002252W WO 2008010008 A3 WO2008010008 A3 WO 2008010008A3
Authority
WO
WIPO (PCT)
Prior art keywords
cardiovascular
rennin
combinations
inhibitors
angiotensin inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2006/002252
Other languages
French (fr)
Other versions
WO2008010008A2 (en
Inventor
Eswaran Krishnan Iyer
Rasendra Kumar Jayantilal Jha
Girish Kumar Jain
Parag Borde
Narayanan Murli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wockhardt Ltd
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2006/002252 priority Critical patent/WO2008010008A2/en
Publication of WO2008010008A2 publication Critical patent/WO2008010008A2/en
Anticipated expiration legal-status Critical
Publication of WO2008010008A3 publication Critical patent/WO2008010008A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention describes new pharmaceutical compositions, their method of manufacture and use of these compositions to be administered as combination therapy for the treatment of cardiovascular and related disorders, in particular a combination of angiotensin II antagonists, lipid regulators (HMG CoA inhibitors), platelet aggregation inhibitors and diuretics.
PCT/IB2006/002252 2006-07-17 2006-07-17 Cardiovascular combinations using rennin-angiotensin inhibitors Ceased WO2008010008A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2006/002252 WO2008010008A2 (en) 2006-07-17 2006-07-17 Cardiovascular combinations using rennin-angiotensin inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2006/002252 WO2008010008A2 (en) 2006-07-17 2006-07-17 Cardiovascular combinations using rennin-angiotensin inhibitors

Publications (2)

Publication Number Publication Date
WO2008010008A2 WO2008010008A2 (en) 2008-01-24
WO2008010008A3 true WO2008010008A3 (en) 2009-04-16

Family

ID=38957139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/002252 Ceased WO2008010008A2 (en) 2006-07-17 2006-07-17 Cardiovascular combinations using rennin-angiotensin inhibitors

Country Status (1)

Country Link
WO (1) WO2008010008A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973942B (en) * 2006-10-30 2015-08-12 韩诺生物制约株式会社 Comprise the controlled release complex composition of angiotensin-ii receptor blockers and HMG-CoA reductase inhibitor
US20120015032A1 (en) * 2007-08-13 2012-01-19 Hanall Pharmaceutical Company, Ltd. Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same
KR101248804B1 (en) * 2010-05-14 2013-03-29 한미사이언스 주식회사 BILAYERED PHARMACEUTICAL COMPOSITION OF HMG-CoA REDUCTASE INHIBITOR AND IRBESARTAN
BR102012020648A2 (en) * 2012-08-17 2014-12-09 Hypermarcas S A SOLID ORAL PHARMACEUTICAL PREPARATION FOR THE PREVENTION OF HEART AND CEREBROVASCULAR DISEASE AND TABLET
KR20140030505A (en) * 2012-08-31 2014-03-12 한미약품 주식회사 Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
CN105232484A (en) * 2015-09-24 2016-01-13 青岛华之草医药科技有限公司 Antipyretic analgesic anti-inflammatory aspirin composition tablet
EP3342400A1 (en) * 2016-12-31 2018-07-04 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. A pharmaceutical composition comprising valsartan and chlorthalidone

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259925A1 (en) * 2003-01-16 2004-12-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
US20050080071A1 (en) * 2001-01-26 2005-04-14 Davis Harry R. Treatment methods
US20050085511A1 (en) * 2003-10-08 2005-04-21 Qiao Jennifer X. Cyclic diamines and derivatives as factor Xa inhibitors
US20050209288A1 (en) * 2004-01-12 2005-09-22 Grogan Donna R Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080071A1 (en) * 2001-01-26 2005-04-14 Davis Harry R. Treatment methods
US20040259925A1 (en) * 2003-01-16 2004-12-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
US20050085511A1 (en) * 2003-10-08 2005-04-21 Qiao Jennifer X. Cyclic diamines and derivatives as factor Xa inhibitors
US20050209288A1 (en) * 2004-01-12 2005-09-22 Grogan Donna R Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use

Also Published As

Publication number Publication date
WO2008010008A2 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
WO2010003127A3 (en) Antagonists of prostaglandin d2 receptors
WO2010127099A3 (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2010037059A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2009108720A3 (en) Antagonists of prostaglandin d2 receptors
WO2010057118A3 (en) Heterocyclic antagonists of prostaglandin d2 receptors
WO2009145989A3 (en) Aminoalkylphenyl antagonists of prostaglandin d2 receptors
WO2010039977A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2010054113A3 (en) Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
WO2007127505A3 (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2011141685A3 (en) Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof
WO2010042652A3 (en) Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
WO2010008864A3 (en) Cycloalkane[b]indole angtagonists of prostaglandin d2 receptors
WO2012080727A3 (en) Casein kinase 1delta (ck1delta) inhibitors
WO2008010222A3 (en) Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating cns disorders
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
WO2009121872A3 (en) Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
MY144857A (en) Phamaceutical composition comprising amlodipine and losartan
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2006010423A3 (en) Azaindole inhibitors of mtp and apob
WO2010085820A3 (en) Tricyclic compounds as antagonists of prostaglandin d2 receptors
WO2011150201A3 (en) Azolyl amide compounds and methods of use thereof
WO2008073350A3 (en) Acetylene derivatives and their use for binding and imaging amyloid plaques
IL186374A (en) Combined use of prostaglandin compound and proton pump inhibitor for manufacture of a pharmaceutical composition for the treatment of gastrointestinal disorders and a pharmaceutical composition comprising them
WO2009099553A3 (en) Use of kinase inhibitor in treatment of atherosclerosis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06795278

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06795278

Country of ref document: EP

Kind code of ref document: A2